GSK launches probe into Iraq bribery claims

Published



LONDON (AP) — GlaxoSmithKline said Monday it has launched an investigation into allegations it bribed doctors in Iraq, as the pharmaceuticals giant remains embroiled in a major corruption scandal in China.

The company said it is probing allegations of “improper conduct in our Iraq business” after reports that it hired 16 doctors and pharmacists in Iraq as paid sales representatives at a time they continued working for the government.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.